The present invention relates to functional foods comprising DAO and their use for the prevention or treatment of diseases or pathological conditions associated with high levels of histamine in blood, in particular for the prevention or treatment of migraine, chronic fatigue, fibromyalgia, spondylitis and pain caused by muscle contractures.

The present invention relates to functional foods comprising DAO and their use for the prevention or treatment of diseases or pathological conditions associated with high levels of histamine in blood, in particular for the prevention or treatment of migraine, chronic fatigue, fibromyalgia, spondylitis and pain caused by muscle contractures.

A process for preparing a particulate dairy composition is provided, which comprises (a) combining condensed skimmed milk, sucrose, milk cream and milk powder to prepare a pre-emulsion containing 46-66 wt. % dry matter; (b) homogenizing the pre-emulsion; (c) spray drying the emulsion to produce a semi-dried powder having a water content of at least 5 wt. % water; and (d) agglomerating and further drying the semi-dried powder to produce agglomerates having a water content of less than 5 wt. % water. The process yields a particulate dairy composition that is particularly suitable for use in creamer capsules. Particulate dairy compositions are also disclosed, comprising (A) 77.5-100 wt. % of agglomerates containing, calculated by dry weight of the agglomerates: (i) 15-29 wt. % of milk protein; (ii) 8-33 wt. % of milk fat; (iii) 18-47 wt. % of lactose; and (iv) 7-18 wt. % of sucrose; and (B) 0-22.5 wt. % of sucrose particles, wherein the composition has a poured bulk density of 380-550 g/l.

The present invention provides novel oral dosage comprising lyophilized mammalian (human) milk and optionally a physiologically acceptable excipient or carrier, and their use for improvement of mammalian (human) health. Also provided a novel process for preparing lyophilized mammalian milk with desired nutritional and cellular content, initially freezing raw milk obtained from a mammalian source, forming a layer of a predefined thickness from the frozen milk at a temperature from −4° C. to −80° C., and drying the formed layer at a temperature from −20° C. to +60° C. at a pressure from 5 micron Hg to atmospheric pressure to provide the lyophilized human milk. The process optionally comprises comprising treating said lyophilized milk via flash supercritical CO.sub.2 treatment comprising soaking said lyophilized milk with supercritical CO.sub.2

The present invention relates to whey protein micelles for use in the treatment and/or prevention of a condition linked to a reduced concentration of plasma amino acids in a patient. A further aspect of the invention is a meal replacement comprising whey protein micelles.

A coated particle may include a food particle coated by a carbohydrate. The coated particle may have an average particle size from about 10 m to about 250 m. The food particle may include a relatively bitter component (e.g., cocoa) and a protein component (e.g., whey protein, soy protein, rice protein, fava bean protein, and/or milk protein). A weight ratio of bitter component to protein component may be about 3 or greater. The food particle may also include a starch, such as rice starch. Additionally, the coated particle may have a surface area fraction of the carbohydrate that is greater than an average weight fraction of the carbohydrate. For example, the surface area fraction of the carbohydrate may be from about 30% to about 80%. In addition, the coated particle may have a substantially non-spherical and irregular shape. The coated particle may be prepared via a spray drying process.

The present invention provides a lactase-containing double microcapsule which includes; lactase provided as a core material; and a primary coating material and a secondary coating material, which are sequentially coated on the core material to be formulated, a method for preparing the lactase-containing double microcapsule, and a dairy product including the lactase-containing double microcapsule as a use of the lactase-containing double microcapsule.

The present disclosure relates to a method of producing lactic acid bacteria dual-coated with protein and polysaccharide by using a protein hydrolysate, and lactic acid bacteria having a dual coating, produced by the method. The lactic acid bacteria having a dual coating of protein and polysaccharide, produced according to the present disclosure, have very excellent dry-freezing viability, acid resistance and bile resistance. Accordingly, the lactic acid bacteria having a dual coating of protein and polysaccharide according to the present disclosure will be very useful for the production of fermented milk, processed milk, fermented soy products, processed foods, functional beverages, functional foods, common foods, etc.

A process for preparing a particulate dairy composition is provided, which comprises (a) combining condensed skimmed milk, sucrose, milk cream and milk powder to prepare a pre-emulsion containing 46-66 wt. % dry matter; (b) homogenizing the pre-emulsion; (c) spray drying the emulsion to produce a semi-dried powder having a water content of at least 5 wt. % water; and (d) agglomerating and further drying the semi-dried powder to produce agglomerates having a water content of less than 5 wt. % water. The process yields a particulate dairy composition that is particularly suitable for use in creamer capsules. Particulate dairy compositions are also disclosed, comprising (A) 77.5-100 wt. % of agglomerates containing, calculated by dry weight of the agglomerates: (i) 15-29 wt. % of milk protein; (ii) 8-33 wt. % of milk fat; (iii) 18-47 wt. % of lactose; and (iv) 7-18 wt. % of sucrose; and (B) 0-22.5 wt. % of sucrose particles, wherein the composition has a poured bulk density of 380-550 g/l.

The present application relates to a microcapsule comprising a core comprising one or more hydrophobic agents dispersed in a gel matrix; a proteolytically-cleavable outer polymer shell surrounding said core; and an enzymatically-cleavable lipid layer between said core and said shell. Also described are methods of making and using the microcapsules.